GL1X · GenesisL1 explorer

MolNFT v1 · #181019 · protein + DNA

K. pneumoniae topoisomerase IV (pare-parc) in complex with DNA and (3S)-10-[(3R)-3-(1-AMINOCYCLOPROPYL)PYRROLIDIN-1-yl]-9-fluoro-3- methyl-5-oxo-2,3-dihydro-5H-[1,4]OXAZINO[2,3,4-IJ]QUINOLINE-6- carboxylic acid (compound 25)

7LHZ · DNA topoisomerase 4 subunit B, DNA topoisomerase 4 subunit…: “K. pneumoniae topoisomerase IV (pare-parc) in complex with DNA and…”. X-ray diffraction, 2 ligands (Y21, MG), 20 pockets (best druggability 0.87). MolNFT v1 #181019 on…

PDB
7LHZ
Type
protein + DNA
Length
2,820 residues
Chains
12
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
DNA topoisomerase 4 subunit B, DNA topoisomerase 4 subunit a chimera; DNA…
EC
5.6.2.2
UniProt
A0A377Y395, A0A486EJ79
Ligands
Y21, MG
Pockets
20 · best druggability 0.87

Structure

x-ray diffraction · 10 distinct chains · 47% helix, 13% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
CDNA topoisomerase 4 subunit B, DNA topoisomerase 4 subunit a chimera (EC 5.6.2.2)protein71446% helix, 15% strandA0A377Y395, A0A486EJ79
DDNA topoisomerase 4 subunit B, DNA topoisomerase 4 subunit a chimera (EC 5.6.2.2)protein67747% helix, 13% strandA0A377Y395, A0A486EJ79
ADNA topoisomerase 4 subunit B, DNA topoisomerase 4 subunit a chimera (EC 5.6.2.2)protein70646% helix, 15% strandA0A377Y395, A0A486EJ79
BDNA topoisomerase 4 subunit B, DNA topoisomerase 4 subunit a chimera (EC 5.6.2.2)protein63150% helix, 12% strandA0A377Y395, A0A486EJ79
P, JDNA (5'-D(P*TP*AP*CP*GP*TP*TP*GP*TP*AP*T)-3')dna10——
KDNA (5'-D(*GP*AP*TP*CP*AP*TP*AP*CP*AP*AP*CP*GP*TP*AP*A)- 3')dna15——
IDNA (5'-D(*GP*AP*TP*CP*AP*TP*AP*CP*AP*AP*CP*GP*TP*AP*A)- 3')dna14——
G, FDNA (5'-D(*GP*AP*TP*CP*AP*TP*AP*CP*AP*AP*CP*GP*TP*AP*A)- 3')dna13——
HDNA (5'-D(P*TP*AP*CP*GP*TP*TP*GP*TP*AP*T)-3')dna8——
EDNA (5'-D(P*TP*AP*CP*GP*TP*TP*GP*TP*AP*T)-3')dna9——

Ligands and binding sites

  • Y21 · (3S)-10-[(3R)-3-(1-aminocyclopropyl)pyrrolidin-1-yl]-9-fluoro-3-methyl-5-oxo-2,3-dihydro-5H-[1,4]oxazino[2,3, 4-ij]quinoline-6-carboxylic acid · ligand · 4 copies · chains D, K, I, J, C, P, A, B, G, F, E, H
  • MG · Magnesium ion · metal · 4 copies · chains C, D, A, B
  • MPD · (4S)-2-methyl-2,4-pentanediol · additive · 2 copies · chains C, A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 20 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110040.870.89123MG, Y21
211720.870.88137MG, Y21
36670.840.8968empty
44310.810.8956empty
55380.810.8762empty

Interfaces

22 interfaces between chains.

  • A–B · 1869 Ų buried · 24 hydrogen bonds · protein-protein
  • C–D · 1843 Ų buried · 20 hydrogen bonds · protein-protein
  • A–G · 821 Ų buried · 12 hydrogen bonds · protein-nucleic
  • C–I · 796 Ų buried · 11 hydrogen bonds · protein-nucleic
  • D–K · 795 Ų buried · 13 hydrogen bonds · protein-nucleic

Compared structures

  • 7LHZ · K. pneumoniae Topoisomerase IV (ParE-ParC) in complex with DNA and… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.